| Date | Title | Description |
| 13.03.2024 | ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors | ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
Wed, Mar 13, 2024 10:00 CET Report this content
ReciBioPharm, the advanced and emerging therapies business uni... |
| 23.01.2024 | Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology | Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
Tue, Jan 23, 2024 14:00 CET Report this content
Partnership will help bring breakthroug... |
| 19.12.2023 | Recipharm harmonizes its global quality operations with Veeva Vault Quality | Recipharm harmonizes its global quality operations with Veeva Vault Quality
Tue, Dec 19, 2023 13:05 CET Report this content
Leading CDMO adopts Veeva Vault QMS, Vault QualityDocs, and Vault Training to standardize quality processes and mana... |
| 11.12.2023 | ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas’ LNP formulations | ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas’ LNP formulations
Mon, Dec 11, 2023 10:00 CET Report this content
ReciBioPharm, the advanced and emerging therapies busine... |
| 05.12.2023 | Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant | Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
Tue, Dec 05, 2023 09:00 CET Report this content
Simon Gardner appointed to support customers to t... |
| 05.09.2023 | Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy | Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
Tue, Sep 05, 2023 09:00 CET Report this content
Global contract development and manufacturing organisation (CDMO) Recipharm is partnering with Ahead Thera... |
| 23.08.2023 | Recipharm makes senior appointments as transition to low global warming potential propellants in pressurised Metered Dose Inhalers gains pace | Recipharm makes senior appointments as transition to low global warming potential propellants in pressurised Metered Dose Inhalers gains pace
Wed, Aug 23, 2023 09:00 CET Report this content
Global contract development and manufacturing orga... |
| 17.08.2023 | Recipharm and Honeywell to speed development of inhalers with a near-zero global warming potential propellant | Recipharm and Honeywell to speed development of inhalers with a near-zero global warming potential propellant
Thu, Aug 17, 2023 12:00 CET Report this content
Partnership will reduce environmental footprint of pressurized metered dose inhale... |
| 02.05.2023 | FDA approves the manufacture of new microbiome-based therapeutic VOWST™ at Recipharm site | FDA approves the manufacture of new microbiome-based therapeutic VOWST™ at Recipharm site
Tue, May 02, 2023 11:30 CET Report this content
Recipharm, a global contract development and manufacturing organization (CDMO), has announced today th... |
| 28.04.2023 | Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics | Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics
Fri, Apr 28, 2023 14:30 CET Report this content
Contract with MIT follows the largest award from FDA’s Center for Biologics Evalua... |
| 04.04.2023 | Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer | Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer
Tue, Apr 04, 2023 08:00 CET Report this content
Global contract development and manufacturing organisation (CDMO) Recipharm, has announ... |
| 16.03.2023 | Stevanato Group collaborates with Recipharm to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive biological products | Stevanato Group collaborates with Recipharm to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive biological products
Thu, Mar 16, 2023 14:00 CET Report this content
The new stra... |
| 09.03.2023 | Recipharm’s Arranta Bio expands RNA process development capacity by 50 per cent to meet increased customer demand | Recipharm’s Arranta Bio expands RNA process development capacity by 50 per cent to meet increased customer demand
Thu, Mar 09, 2023 09:00 CET Report this content
Arranta Bio, a Recipharm company and leading contract development and manufact... |
| 05.12.2022 | Recipharm announces extension of commercial manufacturing to support RedHill Biopharma’s Talicia® to 2026 | Recipharm announces extension of commercial manufacturing to support RedHill Biopharma’s Talicia® to 2026
Mon, Dec 05, 2022 10:00 CET Report this content
Global contract development and manufacturing organisation (CDMO) Recipharm, today ann... |
| 30.11.2022 | Recipharm invests in its single dose nasal platform capabilities | Recipharm invests in its single dose nasal platform capabilities
Wed, Nov 30, 2022 10:00 CET Report this content
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that it is expanding its capabili... |
| 29.04.2022 | Recipharm offers services to enable switch to next generation pMDI propellants | Recipharm offers services to enable switch to next generation pMDI propellants
Fri, Apr 29, 2022 08:00 CET Report this content
Global contract development and manufacturing organisation (CDMO) Recipharm, today announces that it is expanding... |
| 03.03.2022 | I’m Sorry, But Your Unique Selling Point Is BS | Raman Sehgal is the founder of life science agency ramarketing, and the author of the best-selling book, The Floundering Founder. |
| 23.02.2022 | Recipharm invests in new high-speed filling line to meet demand for aseptic products | Recipharm invests in new high-speed filling line to meet demand for aseptic products
Wed, Feb 23, 2022 13:00 CET Report this content
Global contract development and manufacturing organisation (CDMO), Recipharm, is investing to expand its st... |
| 18.02.2022 | Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US | Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US
Fri, Feb 18, 2022 08:00 CET Report this content
Recipharm, a leading global contract development and ma... |
| 18.02.2022 | Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics | Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with the acquisition of Vibalogics
Fri, Feb 18, 2022 08:00 CET Report this content
Recipharm, a global contract development and manufacturing orga... |
| 01.02.2022 | Recipharm acquires GenIbet to bolster Biologics offering | Recipharm acquires GenIbet to bolster Biologics offering
Tue, Feb 01, 2022 11:45 CET Report this content
Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portugu... |
| 27.01.2022 | Recipharm secures vaccine manufacturing deal | Recipharm secures vaccine manufacturing deal Thu, Jan 27, 2022 09:00 CET
Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from i... |
| 12.10.2021 | Modus Therapeutics - Symbiosis Pharmaceutical Services Starts Producing Sevuparin for Modus’ Future Clinical Development in Sepsis/septic shock | Modus Therapeutics - Symbiosis Pharmaceutical Services Starts Producing Sevuparin for Modus’ Future Clinical Development in Sepsis/septic shock Tue, Oct 12, 2021 08:30 CET
STOCKHOLM, SWEDEN – 12 October 2021: Modus Therapeutics Holding AB (... |
| 24.09.2021 | First customer boards Recipharm’s soft mist inhaler technology platform | First customer boards Recipharm’s soft mist inhaler technology platform Fri, Sep 24, 2021 11:00 CET
Resyca, Recipharm’s joint venture with Medspray, has boarded its first pharmaceutical customer on the soft mist inhaler (SMI) platform. An a... |
| 24.08.2021 | Recipharm launches new laboratory to expand analytical services offering | Recipharm launches new laboratory to expand analytical services offering Tue, Aug 24, 2021 11:00 CET
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory a... |
| 15.07.2021 | Recipharm invests in fill finish capacity | Recipharm invests in fill finish capacity Thu, Jul 15, 2021 13:00 CET
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced investment into a new facility in Uttarakhand, India which will see its fill f... |
| 17.03.2021 | 14 Strategies To Get Freelancers On Board With Campaigns Fast | Some quick-turn marketing and advertising campaigns require more heavy lifting than an agency’s current staff can handle by themselves. In these cases, it can be beneficial to bring in contractors or freelancers for reinforcement. |
